ndothelial dysfunction characterized by reduced NO (nitric oxide) bioavailability is commonly recognized as a cause and consequence of most cardiovascular diseases. 1 In the endothelium, NO production mostly arises from the conversion of L-arginine to equimolar amounts of citrulline and NO, catalyzed by eNOS (endothelial NO synthase). In response to agonists or fluid shear stress, eNOS activation requires a cascade of events that start with changes in cytosolic Ca 2+ , translocation of the enzyme from caveolar microdomains to the oxygen-rich cytosol, followed by substrate and cofactors interactions.
ndothelial dysfunction characterized by reduced NO (nitric oxide) bioavailability is commonly recognized as a cause and consequence of most cardiovascular diseases. 1 In the endothelium, NO production mostly arises from the conversion of L-arginine to equimolar amounts of citrulline and NO, catalyzed by eNOS (endothelial NO synthase). In response to agonists or fluid shear stress, eNOS activation requires a cascade of events that start with changes in cytosolic Ca 2+ , translocation of the enzyme from caveolar microdomains to the oxygen-rich cytosol, followed by substrate and cofactors interactions. [2] [3] [4] [5] An additional layer of regulation results from post-translational modifications of eNOS, including activating/inactivating phosphorylation, glycosylation, glutathionylation, nitrosylation, and acetylation. 2, 6 See accompanying editorial on page 2278
Decreased availability of the substrate L-arginine contributes to NO deficiency and endothelial dysfunction. This is observed when the breakdown of L-arginine by arginase is accelerated as reported in the context of aging, diabetes mellitus, and hypertension. In these conditions, elevated serum levels of asymmetric dimethyl arginine (ADMA), the endogenous negative competitor of arginine, also participate in the reduction of NO production. 7 Oxidative stress is another common denominator to many cardiovascular diseases characterized by endothelial dysfunction. In diabetes mellitus, atherosclerosis, or hypertension, generation of superoxide anions (also produced by uncoupled NOS) leads to the formation of (deleterious) peroxynitrite thereby reducing the abundance of bioactive NO. 8, 9 Although eNOS expression is only subject to modest degrees of regulation in physiological conditions, transcriptional and post-transcriptional modes of eNOS regulation are frequently described in pathological states, 10 including heart failure, 11 atherosclerosis, 10, 12 diabetes mellitus, and hypercholesterolemia. 13, 14 Among post-transcriptional regulations, epigenetic mechanisms are less well studied. MicroRNAs (miRNAs/miRs) are highly conserved, small noncoding RNAs which negatively regulate gene expression. The miRNA-199a gene, comprising miR-199a-3p and -199a-5p, was originally described in cancer cells because of its capacity to regulate proliferation 15 and angiogenesis. 16 In the past years, interest arose in the cardiovascular field when van Rooij et al reported that miR-199a takes part in a miRNA signature associated with cardiac hypertrophy and heart failure. [17] [18] [19] Other investigators showed that cardiomyocyte-specific overexpression of miR-199a was sufficient to impair cardiomyocyte autophagy and thereby induce cardiac hypertrophy through mTOR (mammalian target of rapamycin) activation. 20 Paradoxically, another study using myocyte-specific miR-199a-sponge documented that a 20% to 30% decrease in endogenous miR-199a-5p levels leads to physiological cardiac hypertrophy through the upregulation of metabolism-related gene expression. 21 Interestingly, tissue profiling analysis has revealed that miR-199a is highly expressed in rat lung and cardiac tissues. 22 In the heart, miR-199a was predominantly, but not exclusively, expressed in cardiomyocytes. Also, changes in miR199a expression in cardiomyocytes were reported to influence neighboring cells. In particular, an increase in ADMA levels in the culture supernatant of pre-miR-199a-exposed cardiomyocytes actually lowered NO bioavailability in rat cardiac endothelial cells. 23 Although the above studies suggested that miR-199a may play critical roles in various tissues, including blood vessels, whether they are expressed by endothelial cells and if so, whether they regulate endothelial function are largely unexplored. Here, we have used bioinformatic algorithms to predict potential targets of miR-199a in endothelial cells and validated several of them through the dissection of the in vitro and in vivo effects of miRNAs 199a-targeting locked-nucleic acid (LNA) and antagomiR, respectively, on eNOS activity.
Materials and Methods
The authors declare that all supporting data are available within the article (and in the online-only Data Supplement).
Cell Culture and LNA Transfection
Bovine aortic endothelial cells (BAEC) were cultured on 0.2% gelatincoated 12-well plates using DMEM (Gibco) supplemented with 10% FBS and 100U penicillin/100 µg streptomycin. Endothelial cells were plated into 12-well culture plates and transfected with 40 nM LNA targeting miR 199a-3p (Exiqon 4100888-001), -5p (Exiqon 4101096-001), mimics (Qiagen YM00472279 and YM00471589), or scramble sequence (Exiqon 199006-001) overnight using DNA Transfection Reagent (Biotool) in Opti-Mem diluted in DMEM supplemented with 10% FBS without antibiotics. Transfection was stopped by replacing transfection medium with complete culture medium (DMEM+FBS 10%+antibiotics). For the immunoblotting, cells were collected 48 or 72 hours after transfection in lysis buffer (Tris HCl 50 mmol/L, NaCl 150 mmol/L, EDTA 1 mmol/L, 0.1% SDS, 0.5% sodium deoxycholate, Triton-100× 10%) containing a protease inhibitor cocktail (Sigma) and a phosphatase inhibitor (Roche). Transfection efficiency was characterized by studying the modulation of direct targets of miR199a-3p, -5p in endothelial cells after inhibition of these miRNAs.
Pharmacological Treatments
For the PI3K (phosphoinositide 3-kinase)/Akt (protein kinase B) inhibition experiments, LY294002 treatment (LY, 20 µM; Millipore) was initiated 1 day before LNA transfection and maintained up to the harvesting of the cells. For inhibition of VEGFA (vascular endothelial growth factor A), Bevacizumab (2 µM; Roche) was used during LNA transfection and maintained up to harvesting. Forty-eight hours after transfection, cells were collected in RIPA lysis buffer to perform immunoblotting.
LNA and Akt1 siRNA Cotransfection
To study the implication of Akt1 in the pathway modulated by miRNA inhibition, we have proceeded in 2 steps. Endothelial cells were plated into 12-well culture plates and transfected during 5 hours with 50 nM of siRNA (small-interfering RNA) directed against Akt1 (Riboxx) using Lipofectamine RNAimax (Invitrogen) in OptiMem diluted in DMEM supplemented with 10% FBS. Transfection was stopped by adding complete culture medium (DMEM+FBS 10%+antibiotics). After overnight recovery, cells were transfected with 40 nM of each LNA or control sequence using Lipofectamine RNAimax in Opti-Mem diluted in DMEM supplemented with 10% FBS. Once again, transfection was stopped by adding complete culture medium (DMEM+FBS 10%+antibiotics). Cells were collected 48 hours after the second transfection in RIPA lysis buffer. 
miRNA Extraction

NO Measurement on Cells
Electron paramagnetic resonance (EPR) spectroscopy was used to detect NO production in Immunofluorescence BAEC cells were fixed in paraformaldehyde 4% for 10 minutes at RT, washed in PBS, and blocked for 1 hour at RT in PBS containing 0.1% saponin and 5% BSA. PRDX1 (peroxiredoxin 1) was detected by incubating the fixed cells with anti-PRDX1 rabbit primary polyclonal antibody (5 µg/mL; Abcam, ab15571) in PBS/saponin 0.1%/BSA 1% at 4°C overnight, followed by incubation with Alexa Fluor 488-conjugated goat anti-rabbit (6 µg/mL; Life's technologies) for 1 hour at 37°C. Cells were incubated with Dapi nuclear stainer (1:10 000 in PBS) for 5 minutes at RT and mounted with Dako fluorescent Medium (Dako). Negative controls were performed by incubation with the secondary antibody only.
Dihydroethidium Staining
Dihydroethidium is able to permeate cells. In the presence of superoxide anion, it is oxidized to 2-hydroxyethidium and ethidium, which are trapped by intercalation with DNA resulting in bright red fluorescence.
In brief, cells were cultured in 12-well vessels on gelatin-coated cover glasses and transfected with LNA, as described above. After 48 hours, cells were washed with PBS and incubated in the presence of dihydroethidium (10 µM) for 1 hour at 37°C. Cells were incubated with Hoechst nuclear stainer (1:10 000 in PBS) for 5 minutes at RT and mounted with Dako fluorescent Medium (Dako). Nuclear staining of dihydroethidium is directly analyzed using Axioskop 40 microscopy system.
ADMA Measurement
To assess ADMA level in culture media, ADMA high sensitive ELISA kit from DLD diagnostika GMBH (EA209/96) was used following the manufacturer recommendations. In brief, ADMA in the samples is acylated and competes with ADMA bound in the microtiter plate for a fixed number of rabbit anti-ADMA antiserum binding sites. The absorbance is read at 450 nM with spectrophotometer and is inversely proportional to the ADMA concentration of the sample.
Angiogenesis Test
BAEC were transfected overnight with LNA or scramble sequence on 0.2% gelatin-coated plates. After transfection, cells were trypsinized, counted, and mixed in equal volume with growth factor-reduced Matrigel (≈10 mg/mL proteins). Each mixture was put in culture in 12-well plate. After polymerization of the Matrigel for 1 hour at 37°C, each well containing mixture with cells was covered with 500 µl of complete medium. Each condition was performed in duplicate. After 48 and 72 hours, cells underwent migration and alignment to form tubes.
Luciferase Assay
A 3' UTR (untranslated region) fragment of the VEGFA, calcineurin, and SOD1 mRNAs were subcloned by using In-Fusion HD Cloning Kits (Clonotech) according to manufacturer's instruction, into the pmiRGlo Dual-Luciferase vector (Promega) immediately downstream of 3´ of the firefly luciferase gene (luc2). The miR-199a/a* mature sequence was cloned into the pcDNA6.2-GW/EmGFP-miR vector according to the manufacturer's protocol (Thermo Fisher Scientific). HEK (human embryonic kidney)-293T cells were transfected with pmiRGlo-3'UTR and pcDNA6.2-GW/ EmGFP-miR-199a/a* (miR-199a-5p/-3p) plasmids. Forty-eight hours post-transfection, cells were lysed, and luciferase activity was measured using the Nano-Glo Dual-Luciferase Reporter (NanoDLR) Assay System as described by the manufacturer (Promega). To confirm specific targeting of the 3'UTR of target genes by miR-199a/a*, site-specific mutagenesis at the predicted sites were obtained by using the QuikChange Site-Directed Mutagenesis Kit according to the manufacturer's instructions (Agilent technologies). Mutated constructs were then tested in luciferase assays, and the rescue of chemiluminescent signal in the presence of miR-199a/a* identified real targeting sites. Moreover, alignments between human and bovine sequences were performed using clustalW and assessed that within the calcineurin gene, the putative binding sites for both miR199a family members are conserved between Homo Sapiens and Bos Taurus. VEGFA gene has only the region containing the putative binding site for miR-199a-5p, which is conserved between the 2 species. Concerning SOD1 gene, conservation of miR-199a-3p and -5p sites is almost identical except for few nucleotides between Homo Sapiens and Bos Taurus.
Animals and Treatments
All experimental procedures and protocols were approved by the local Ethics Committee (Comité d'Ethique pour l'Expérimentation animale), Secteur des Sciences de la Santé, Université Catholique de Louvain, according to National Care Regulation and Directive 2010/63/EU of European Parliament and of the Council. Only male mice were used in this study to avoid confounding effects. Indeed, estrogens are well-characterized modulators of endothelial function through regulation of the NOS/NO pathway.
Seven-week-old C57Bl6 male mice (30 animals) were injected in caudal vein 3 days in a row with a specific antagomiR (Fidelity systems, 75 mg/kg per day) directed against miR-199a-3p and -5p specifically, a scramble sequence or saline solution. [25] [26] [27] These injections were performed each day by the same experimented technician. Mice were then housed 1 per cage in a 12/12-hour night and day cycle for 30 days, and their behavior was checked every day. At the day of the euthanization, blood and vessels were collected; the arteries were mounted on a wire myograph to evaluate the endotheliumdependent response, some vessels samples were frozen for further analysis (Western blotting as described above). Blood samples were used for assessment of NO and superoxide anion rates by EPR or plasma isolated for miR profiling.
Twelve-week-old C57Bl6/J male mice (12 animals) were treated with continuous infusion of angiotensin II (2 mg/kg per day) or saline solution during 14 days using osmotic minipumps (Alzet 2002) subcutaneously implanted between the scapulae in anesthetized mice with Isoflurane, as described in the literature. 28 Mice were housed 1 per cage after the implantation of the minipumps, and their wellbeing was checked every day. After 14 days, terminal anesthesia was performed by intraperitoneal injection of ketamine (100 mg/ mL) and xylazine (20 mg/mL), mice were weighed, blood, heart, and vessels were collected and frozen in liquid nitrogen for further miR profiling.
Bias and Randomization
All mice were cared for equally in an unbiased fashion by animal technicians and investigators. Mice were randomly allocated into 4 groups ( Figure 6 ) or 2 groups (Figure IX in the online-only Data Supplement). Although the mouse groups were not blinded, the people involved in functional studies on vessel relaxation, in hemoglobin-NO (HbNO) dosage, osmotic pump surgical implantation, and quantitative PCR were different, and data were never shared between them up to article writing. In addition, HbNO dosage and osmotic pump-related surgery were performed by platform logisticians and quantitative PCR by Masters students who were not aware of the nature of the study. Finally, we took care of adding a saline solution condition besides the antagomir scramble control to exclude any bias related to the mouse injection, including the stress associated with mouse handling. For the same reasons, minipumps loaded with saline solution were implanted to be used as the most appropriate control of angiotensin-loaded pumps.
NO Measurement in Venous Blood
NO bioavailability was assayed as the concentration of circulating hemoglobin nitrosylated at heme-FeII (HbNO) in vivo. Whole venous blood of male C57Bl6 mice treated or not with antagomiRs against miR-199a-3p, -5p or scrambled antagomiR was collected and frozen immediately in calibrated tubes as previously described. 29 The EPR spectra were recorded by a Bruker spectrometer (AMXmicro, X-band; microwave frequency 9.35 GHz, modulation frequency 100 kHz) with following setting: microwave power, 20 mW; modulation amplitude, 0.7 mT; 5 scans, at 77 K using a finger dewar. The level of HbNO was quantified from hyperfine structure (gz=2.011; Az=16.8G) of the EPR signal after digital subtraction of a signal of protein-centered free radicals (g=2.005; linewidth≈19G) using Bruker software, Xenon. Samples were normalized by volume.
Anion Superoxide Measurement in Aortic Rings
Superoxide anion production was assayed quantitatively by EPR in isolated aortic rings using reactive oxygen species (ROS)-sensitive spin probe at 1 mmol/L (1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine, CM-H; Alexis Biochemichal, Inc) in situ, as previously described. 30 In brief, aortic rings were preincubated in KREBS-DTPA (diethylenetriaminepentaacetic acid)-Hepes buffer (0.1 mmol/L DTPA, 20 mmol/L HEPES, pH 7.5) in presence or not of SOD (100U/mL). Then the aortic rings were inserted in capillaries and the kinetics of the CM-H EPR signal formation was recorded online in capillary interposed into the cavity of the EPR spectrometer during 10 to 15 minutes at 37°C (10 scans) using the X-band EPR spectrometer MS400, Magnettech (microwave frequency, 100 kHz; microwave power, 20 mW; modulation amplitude, 0.1 mT). The rate of the CM . radical formation was calculated as a slope of linearized kinetic curve. Results were normalized by the length of aortic ring. SOD-sensitive signal was accepted as superoxide anion formation.
Myograph Experiments
Thoracic aortic arteries were mounted in a wire myograph. NO-mediated relaxation was measured as previously described. 31, 32 In brief, 2 40 µm wires were threaded into the lumen of the vessel segments and incubated in a bath continuously perfused with physiological solution, gassed, and maintained at 37°C. Aorta from antagomiR-treated or control mice was contracted with a high-KCl solution (to prevent implication of endothelium-derived hyperpolarization) in the presence of indomethacin (10 µmol/L), a Cox2 (cyclooxygenase-2) inhibitor, and exposed to an increased concentration of acetylcholine.
Statistical Analyses
All experiments were reproduced at least 3×. All data are expressed as the mean±SEM. Shapiro-Wilk normality test and Bartlett or Levene equal variance tests were performed, and statistically significant differences were determined using a 2-way ANOVA or 1-way ANOVA followed by Tukey-Kramer post hoc ANOVA test or by using a Kruskal-Wallis test for nonparametric data. P<0.05 was considered statistically significant.
Results
miR-199a-3p and miR-199a-5p Are Expressed in Endothelial Cells
As a preamble to this study, we first evaluated the expression of the mature miR-199a arising from both arms of the precursor miR-199a, respectively miR-199a-3p (3'arm) and miR199a-5p (5' arm) in human and BAEC. Of note, sequences of human and bovine miR-199a are strictly identical. Both mature miRNAs were detected in significant and similar amounts in endothelial cells (PCR threshold cycle values for miR-199a-5p and -3p in BAEC: Ct 27.4 and 27.5 and in human aortic endothelial cells: Ct 26.3 and Ct 26.4, respectively). We used bioinformatic algorithms (target scan, Pictar, miRNA.org) to predict potential targets of miR-199a-3p and -5p in endothelial cells, in particular in the eNOS/NO pathway (Table) . Although eNOS gene per se was not identified as a theoretical target for either miR-199a, matching sequences were identified in a series of genes coding for proteins related to the NO pathway (see below). Matching between miR199a-3p or miR-199a-5p and some of the predicted targets were verified using luciferase-based reporter assays. As highlighted in Figure I in the online-only Data Supplement, both miR-199a-3p and miR-199a-5p target the 3'UTR region of VEGFA, Calcineurin, and SOD1 mRNA.
NO Production Is Increased After Repression of miR-199a-3p or miR-199a-5p in Endothelial Cells
Transfection of LNA directed against either arm of miR-199a was effective in reducing the expression of the targeted miR as measured 48 or 72 hours after transfection ( Figure IIA and IIB in the online-only Data Supplement). LNA-based repression of miR-199a-3p or miR-199a-5p practically doubled basal NO production in BAECs (Figure 1) . Treatment of BAECs with the nonselective NOS inhibitor L-nitroarginine methyl ester reduced NO levels to baseline amounts, indicating that miR-199a-3p or -5p blockade somehow led to an increase in NOS synthase(s) activity or in bioavailable NO. The expression of eNOS (the predominant NOS isoform expressed in endothelial cells) was not significantly altered by repression of miR-199a-3p or -5p (see total eNOS in Figure 2A) . Similarly, expression of Cav1 and hsp90, 2 critical eNOS regulators in endothelial cells, remained unaltered after LNA treatments ( Figure III in the online-only Data Supplement). Also, neither the presence (in culture media) of ADMA, the endogenous competitive substrate for eNOS, nor the expression of its production/degradation enzymes in endothelial cells, namely DDAH1 and PRMT1 (the latter being a theoretical potential miR-199a target [Table] ), were affected by either LNA treatments ( Figure IVA -IVC in the online-only Data Supplement).
eNOS Phosphorylation on Ser1177 is Modulated by miR-199a-3p and miR-199a-5p Repression Through the PI3K/Akt Pathway
Post-translational modifications of eNOS include changes in its phosphorylation state. We found that miR-199a-3p and -5p repression independently induced a prolonged increase in These scores are representative of an alignment of the seed sequence of the miRNA of interest with mRNA in humans; last column is miRSVR score in mouse. Akt indicates protein kinase B; CAV, caveolin; DDAH, dimethylarginine dimethylaminohydrolase; eNOS, endothelial NO synthase; HSP, heat shock protein; miR/ miRNA, microRNA; miRSVR, miR scoring by vector regression; n.i., nonidentified matching sequences; NO, nitric oxide; PDK, pyruvate dehydrogenase kinase; PRDX, peroxiredoxin 1; PRMT, protein arginine N-methyltransferase; SOD, superoxide dismutase; and VEGFA, vascular endothelial growth factor A.
eNOS phosphorylation on Ser1177 (Figure 2A ) after transfection of BAECs with either LNAs. These results correlated with a significant increase in Thr308 Akt phosphorylation 48 and 72 hours after the initiation of miRNA repression ( Figure 2B ). Similar results were observed in human aortic endothelial cells (data not shown). To prove a role of Akt in the LNAsupported increase in Ser1177 eNOS phosphorylation, we repeated the above experiments after silencing of Akt1, 33, 34 the sole Akt isoform associated with eNOS 34 phosphorylation, and after treatment with the PI3K inhibitor LY294002. Akt1 siRNA treatment blunted the LNA-induced eNOS activation ( Figure 2C ), whereas LY294002 prevented both the phosphorylation of Akt on Thr308 and the increase in Ser1177 eNOS phosphorylation resulting from miR-199a-3p or -5p blockade ( Figure 2D ). Of note, we did not identify any effects of either LNA on the expression of PDK1 ( Figure V in the online-only Data Supplement), the master kinase responsible for the activation of Akt (downstream of PI3K) identified as a potential miR-199a target (Table) . In agreement with these results, transfection of miR-199a-3p or miR-199a-5p mimics evoked a decrease of eNOS activation through its phosphorylation on Ser1177 ( Figure VIA in the online-only Data Supplement).
eNOS Phosphorylation on Thr495 is Modulated by miR-199a-3p and miR-199a-5p Repression Through the Calcineurin Pathway
Another well-known regulatory phosphorylation site within the eNOS sequence is the inactivating site, Thr495. We observed that LNA-based repression of miR-199a-3p and miR-199a-5p independently induced a decrease in the extent of Thr495 eNOS phosphorylation ( Figure 3A) . Importantly, we found that expression of calcineurin, the well-described phosphatase for Thr495 phosphorylated eNOS, was increased by >50% when miR-199a-3p or -5p were repressed ( Figure 3B ) in agreement with the identification of the calcineurin mRNA as a potential molecular target of miR-199a (Table) . Accordingly, miR-199a-3p or -5p mimics transfection significantly reduced the phosphatase expression ( Figure VIB in the online-only Data Supplement).
Repression of miR-199a-3p and miR199a-5p Modulates the NO Bioavailability by Modulating SOD1 Expression
The above experiments indicated that miR-199a repression was associated with an increase in eNOS activity. We next evaluated whether the increase in NO abundance (Figure 1 ) could also arise from a decreased NO degradation because of a lesser reaction with superoxide anions (O 2 − ·). We first documented that repression of both miR-199a-3p and miR-199a-5p induced a marked reduction of O 2 − · levels in endothelial cells, as measured by dihydroethidium staining ( Figure 4A ). We also examined the expression of 2 ROS-regulating enzymes that we identified among the theoretical targets of miR-199a (Table) , namely SOD1 and PRDX1, which catalyze the dismutation of O 2 − · into hydrogen peroxide (H 2 O 2 ) and transforms H 2 O 2 in oxygen and water, respectively. We found that both miR-199a-targeting LNAs led to a net increase in SOD1 ( Figure 4B ), whereas PRDX1 expression was only increased on transfection with miR-199a-5p-targeting LNA ( Figure VII in the online-only Data Supplement).
Inhibition of miR-199a-5p Induces an Increase in VEGFA Protein Expression and Tube Formation
We next aimed to evaluate the effects of dedicated LNA on endothelial tube formation, a process known to be NO-mediated. This experiment was further guided by previous reports and our luciferase-based reporter assay identifying VEGFA (comprising all splicing variants) as a putative direct target of miR-199a-5p 35 (Table) . Note that the absence of pairing between bovine VEGFA and miR-199a-3p is likely to account for the lack of regulation by LNA3p in BAECs. We confirmed an increase in VEGFA expression in cells transfected with miR-199a-5p inhibitor (but not miR-199a-3p; Figure 5A ). Bevacizumab treatment of endothelial cells partially inhibited eNOS phosphorylation on Ser1177 observed following LNA5p transfection ( Figure VIII in the online-only Data Supplement). In addition, the extent of precapillary tube formation, as assessed by plating endothelial cells on Matrigel and quantified with Image J software, was increased in response to miR-199a-targeting LNA, in particular when miR-199a-5p was repressed ( Figure 5B and 5C ).
Mice Treated With AntagomiRs Directed Against miR-199a-3p and miR-199a-5p Present an Improvement of Their Endothelial Function
To prove that miR-199a repression influences the amounts of bioactive NO in vivo, C57Bl6 male mice were treated with antagomiRs directed against miR-199a-3p or miR199a-5p. At the time of euthanization (30 days after the initiation of in vivo antagomiR administration), plasma was Figure 1 . MicroRNA (miR) 199a-3p or -5p inhibition induces changes in nitric oxide (NO) production in endothelial cells. Bovine aortic endothelial cells were transfected with locked-nucleic acid (LNA) directed against miR-199a-3p or -199a-5p, and NO production was measured by electron paramagnetic resonance spin trapping after exposure to the spin trap colloid complex [(diethyldithiocarbamate) 2 Fe(II)] for 45 min. Results are expressed as mean±SEM. Numbers of individual experiments are the following: Scramble,n=6; LNA a-3p, n=6; LNA a-5p, n=4; Scramble+ L-nitroarginine methyl ester (L-NAME), n=3; LNA a-3p+L-NAME, n=3 and LNA a-5p+L-NAME, n=3. *P<0.05 and **P<0.01 vs control (ctrl); $P<0.05 and $$P<0.01 vs L-NAME treatment.
collected to verify the expression of circulating miRs. A specific decrease of the targeted miR was observed without significant alterations in the expression of the opposite strand ( Figure IIC and IID in the online-only Data Supplement). Isolated aorta presented a significantly larger NO-dependent relaxation as measured in KCl precontracted vessels (versus vessels from mice treated with saline or scramble sequence; Figure 6A ). These results were further validated by the detection of increased levels of circulating hemoglobin-NO (HbNO) in the venous blood of antagomiR-treated mice ( Figure 6B) . Also, EPR measurements of O 2 − · production in aortic rings obtained from mice treated with antagomiRs against miR-199a-3p or -5p revealed a net reduction in O 2 − · levels (versus control conditions; Figure 6C ). In agreement with the data obtained in cultured endothelial cells, an increase of eNOS phosphorylation on Ser1177 ( Figure 6D ) was observed in the aorta of antagomiR-treated mice (versus control mice). Moreover, an increase of calcineurin and SOD1 expression ( Figure 6E and 6F) was also identified in isolated vessels 
miR-199a-3p and miR-199a-5p are Increased in Mice Model of Hypertension
To verify the implication of miR-199a in pathological conditions, mice were implanted with angiotensin infusing minipump (2 mg/kg per day) for 14 days, a well-described model of hypertension and cardiac hypertrophy. 29 Heart and aorta isolated from these mice exhibited a larger expression of both mature miR-199a. Interestingly, a dysregulation of miR expression was only observed for miR-199a-5p in the plasma of hypertensive mice ( Figure IX in the online-only Data Supplement).
Discussion
miRNAs derived from the precursor miR-199a are known to play critical roles in the maintenance of cardiac homeostasis. 19, 36 Our study reveals that both mature miRNAs (namely miR-199a-3p and miR-199a-5p) also participate in a redundant network of eNOS regulation in the endothelium (see Graphic Abstract). In particular, we highlighted how inhibition of miR-199a-3p and miR-199a-5p independently increases NO bioavailability by promoting eNOS enzymatic activity and reducing NO degradation, thereby, supporting VEGFA-induced endothelial tubulogenesis and modulating vessel contractile tone. miR-199a is well conserved in different species 37 and in the human genome, it is encoded by 2 loci within introns of the DNM (dynamin 2 and 3), miR-199a-1 in chromosome 19 and mir-199a-2 in chromosome 1. Classically, 1 of the 2 strands derived from the precursor is considered as mature (miR) and the other one (miR*) is degraded, the ratio miR/miR* varying according to the rate of degradation of the immature strand. There is, however, growing evidence that both strands might exhibit regulatory activities. 38 Accordingly, both strands (-5p and -3p) from pre-miR-199a can form mature miRNAs that may behave differently depending on the pathological contexts. 37 In this study, we found that both miRNAs, miR199a-3p and miR-199a-5p were significantly expressed in endothelial cells and independently regulated NO production. Based on various in vitro and ex vivo assays, we found that NO availability was increased through an increased eNOS enzymatic activity, an effect further reinforced by reduced superoxide production.
Strikingly, we identified that the eNOS phosphorylation status was altered not only on the stimulatory Ser1177 site but also on the inactivating Thr495 site. We identified the stimulatory effects of miR-199a-3p and -5p-targeting LNAs on the PI3K/Akt pathway and on the calcineurin phosphatase as the respective triggers of this mode of eNOS activation. The upregulation of calcineurin on miR-199a blockade was in agreement with the in silico identification of calcineurin-encoding gene as a theoretical target of this miRNA (see Table) and further validated by a dedicated luciferasebased reporter assay. By contrast, although pharmacological inhibition of PI3K and Akt genetic silencing proved the role of this pathway on Ser1177 phosphorylation, we did not observe changes in the abundance of Akt (or PDK1) on LNA treatment (despite favorable matching scores between miRNAs sequences and Akt mRNA [Table] ). Further studies are warranted to identify possible targets involved in the regulation of the PI3K/AKT pathway. Interestingly, the miR199a-mediated regulation of Akt was recently highlighted in mouse heart as supportive of physiological cardiac hypertrophy, 21 myoblast differentiation 39 and cardiomyocyte proliferation, 40 and survival under ischemic stress. 41 Interestingly, besides increased eNOS activity resulting from increased Ser1177 phosphorylation and Thr495 dephosphorylation, our study also provides evidence that miR-199 blockade can increase NO bioavailability by preventing its inactivation. We actually found that SOD was increased on repression of miR-199a-3p or -5p, thereby, supporting a reduced oxidative stress and thus promoting an increase in NO availability. It is also worth noting that although similar effects (ie, changes in eNOS phosphorylation and SOD activity) were obtained with LNA targeting either miR-199a form, repression of miR-199a-5p exhibited a significantly stronger effect on the upregulation of PRDX1 (another ROS detoxifying enzyme) than on miR-199-3p blockade. A large effect of miR-199a-5p-targeting LNA was observed on VEGFA expression and endothelial tube formation. However, we cannot exclude that in human endothelial cells, miR-199a-3p could also regulate VEGFA to some extent. The respective contribution of VEGFA overexpression to eNOS activation in our experimental setup is actually difficult to delineate because Akt phosphorylation itself (a main driver of eNOS phosphorylation) is independently increased in response to LNA treatment. Nevertheless, altogether, these data reinforce . MicroRNA (miR) 199a-3p or -5p inhibition induces a reduction in superoxide anion production in endothelial cells through an increase in SOD1 (superoxide dismutase 1) expression. Bovine aortic endothelial cells were transfected with locked-nucleic acid (LNA) directed against miR-199a-3p or -199a-5p, and superoxide anion levels were assessed by dihydroethidium (DHE) staining (A, red) and quantified (see bar graph); nucleus was counterstained using Hoechst dye (A, blue). Expression of SOD1 was detected by Western blotting and quantified (B). Results are expressed as mean±SEM. Numbers of individual experiments are the following: n=3 for each condition for DHE staining and n=4 for each condition for SOD1 quantification. *P<0.05 and **P<0.01 vs control (ctrl). Scr indicates scramble.
the redundant aspect of miR-199a regulation on the endothelial NOS/NO pathway.
Importantly, in our study, the effects of chronic mouse exposure to anti-miR-199a antagomiRs further provided several sets of evidence supporting a relevant role of miR-199a in in vivo settings. We have indeed observed a dramatic increase in the relaxation of vessels isolated from antagomiR-treated mice together with a reduced superoxide production and an increased circulating HbNO reflecting a global increase in NO availability. Modifications of eNOS phosphorylation, calcineurin, and SOD expression also argue in favor of a role of miR-199a-3p and 5p in vivo. It should be noted that previous publications have reported effects of either miR-199a-5p or -3p on eNOS activity through changes in Cav expression. 42 In our hands, such regulation could not be observed, possibly suggesting differential miRNA regulation processes in different cell types or physio-pathological contexts. Also, we failed to document a link between the expression of miR-199a and the abundance of the endogenous eNOS inhibitor ADMA (and of the related producing/metabolizing enzymes), as previously reported in cardiomyocytes. 23 However, the latter observation could result from differential targeting according to the cellular context (ie, cardiac myocytes versus endothelial cells) or nonspecific effects resulting from the overexpression of pre-miR-199a.
Taken together, our results indicate that miRNAs matured from miR-199a, working potentially in cluster, take part in a redundant network of regulation of the NOS/NO pathway in the endothelium and modulate key endothelial functions, including angiogenesis and vascular tone. miR-199a has, therefore, to be added to the short list of miRNAs reported to modulate eNOS expression or activity, such as miR-155 and miR-21. 43 Our observations are in agreement with studies documenting that miRNAs often fine-tune cellular homeostasis through . Vessels isolated from mice treated with microRNA (miR)-199a-3p or -199a-5p inhibitors exhibit an increased endothelium-dependent nitric oxide (NO)-dependent relaxation. Mice were treated on 3 consecutive days with antagomiRs (75 mg/kg per day) against miR 199a-3p/-5p and euthanized 30 d after treatment. Dose-dependent effects of acetylcholine on mouse aorta relaxation determined on a wire myograph (A). Venous blood from these mice (B) and aortic rings (C) were also collected to assess hemoglobin-NO (HbNO) and superoxide anion levels, respectively, by electron paramagnetic resonance. Level of Ser1177 phosphorylated eNOS (endothelial NO synthase), calcineurin, and SOD1 (superoxide dismutase 1) was detected by Western blotting and quantified (D-F). Results are expressed as mean±SEM of at least 5 animals for physiological experiments and 6 (D-E) or 4 (F) animals for Western blot experiments *P<0.05, **P<0.01 and ***P<0.001 vs indicated controls (saline or scramble).
intercrossed regulatory networks controlled by multiple miRNAs. 44 More specifically, the dysregulation of both mature arms of miR-199a initially reported in heart may now be extended to the vascular tissues, thereby opening new perspectives of treatment. Our study actually provides evidence that new therapeutic opportunities may stem from altering these subtle modes of regulation in blood vessels, for instance through the use of endothelial-directed aptamer inhibitors or miRNA-sponges.
